1st Mount Sinai Symposium on Liver Fibrosis & Hepatic Stellate Cells

The meeting features an exceptional lineup of globally recognized experts from North America and Europe, including keynote lectures from pioneers in fibroblast biology, mechanotransduction, organoid modeling, and translational fibrosis research. The program spans state-of-the-art topics such as cellular heterogeneity, spatial multi-omics, AI-enabled pathology, fibroinflammatory niches, and emerging anti-fibrotic therapies, with technology demonstrations and an interactive panel. Designed to foster cross-disciplinary exchange, this timely conference offers scientists and physician-scientists an unparalleled opportunity to engage with transformative ideas shaping the future of fibrosis biology and therapy. Objectives 1. Review the historical evolution and current understanding of hepatic stellate cells and their role in liver fibrosis. 2. Examine hepatic stellate cell heterogeneity, plasticity, and mechanobiology across chronic liver disease states. 3. Describe the cellular, immunologic, and stromal mechanisms linking fibrosis to inflammation and hepatocellular carcinoma. 4. Evaluate emerging technologies, including spatial multi-omics, AI-based pathology, SHG imaging, and MRE, for fibrosis assessment. 5. Discuss current and future antifibrotic therapeutic strategies, including cellular-based approaches and translational trial design. The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA PRA Category 1 Credits™ (6.25 hours), Non-Physician Attendance (6.25 hours) All refund and cancellation requests must be emailed to the CME office at [email protected] by November 27, 2026. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal or less than $50.